Anders Johansson

Title: The Innovations of Anders Johansson

Introduction

Anders Johansson is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of biotechnology, particularly through his research on toxins. His work has implications for understanding cytotoxic activities and their effects on various species.

Latest Patents

Anders Johansson holds a patent related to the identification and initial characterization of CctA, a novel secreted toxin. This toxin represents the major cytotoxic activity and confers strong hemolytic activity towards erythrocytes of various species. The patent indicates that anti-CctA antibodies can fully neutralize hemolysis on standard blood-agar medium or in cell-free supernatants of liquid cultures. He has 1 patent to his name.

Career Highlights

Throughout his career, Johansson has worked with prominent organizations, including Intervet International B.V. and Universität Bern. His research has contributed to advancements in understanding toxic substances and their biological effects.

Collaborations

Anders Johansson has collaborated with notable colleagues such as Keith Redhead and Joachim Frey. These partnerships have enhanced his research and broadened the impact of his findings.

Conclusion

Anders Johansson's work in the field of biotechnology, particularly his research on CctA, showcases his innovative contributions to science. His collaborations and career highlights reflect his commitment to advancing knowledge in this important area.